A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune Response
Abstract
:1. Introduction
2. Results
3. Discussion
4. Materials and Methods
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Tsou, P.; Katayama, H.; Ostrin, E.J.; Hanash, S.M. The Emerging Role of B Cells in Tumor Immunity. Cancer Res. 2016, 76, 5597–5601. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Garaud, S.; Buisseret, L.; Solinas, C.; Gu-Trantien, C.; de Wind, A.; Van den Eynden, G.; Naveaux, C.; Lodewyckx, J.-N.; Boisson, A.; Duvillier, H. Tumor-infiltrating B cells signal functional humoral immune responses in breast cancer. JCI Insight 2019, 5, e129641. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hanash, S. Harnessing immunity for cancer marker discovery. Nat. Biotechnol. 2003, 21, 37–38. [Google Scholar] [CrossRef]
- Le Naour, F. Identification of tumor antigens by using proteomics. Methods Mol. Biol. 2007, 360, 327–334. [Google Scholar] [PubMed]
- Pereira-Faca, S.R.; Kuick, R.; Puravs, E.; Zhang, Q.; Krasnoselsky, A.L.; Phanstiel, D.; Qiu, J.; Misek, D.E.; Hinderer, R.; Tammemagi, M.; et al. Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer. Cancer Res. 2007, 67, 12000–12006. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lu, H.; Goodell, V.; Disis, M.L. Humoral Immunity Directed against Tumor-Associated Antigens As Potential Biomarkers for the Early Diagnosis of Cancer. J. Proteome Res. 2008, 7, 1388–1394. [Google Scholar] [CrossRef] [Green Version]
- Babel, I.; Barderas, R.; Díaz-Uriarte, R.; Martínez-Torrecuadrada, J.L.; Sanchez-Carbayo, M.; Casal, J.I. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol. Cell. Proteom. 2009, 8, 2382–2395. [Google Scholar] [CrossRef] [Green Version]
- Massoner, P.; Lueking, A.; Goehler, H.; Höpfner, A.; Kowald, A.; Kugler, K.G.; Amersdorfer, P.; Horninger, W.; Bartsch, G.; Schulz-Knappe, P. Serum-autoantibodies for discovery of prostate cancer specific biomarkers. Prostate 2012, 72, 427–436. [Google Scholar] [CrossRef]
- Babel, I.; Barderas, R.; Diaz-Uriarte, R.; Moreno, V.; Suarez, A.; Fernandez-Aceñero, M.J.; Salazar, R.; Capellá, G.; Casal, J.I. Identification of MST1/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays. Mol. Cell. Proteom. 2011, 10, M110.001784. [Google Scholar] [CrossRef] [Green Version]
- Hong, S.-H.; Misek, D.E.; Wang, H.; Puravs, E.; Giordano, T.J.; Greenson, J.K.; Brenner, D.E.; Simeone, D.M.; Logsdon, C.D.; Hanash, S.M. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer. Cancer Res. 2004, 64, 5504–5510. [Google Scholar] [CrossRef] [Green Version]
- Nam, M.J.; Kee, M.K.; Kuick, R.; Hanash, S.M. Identification of defensin α6 as a potential biomarker in colon adenocarcinoma. J. Biol. Chem. 2005, 280, 8260–8265. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Landry, C.R.; Zhong, X.; Nielly-Thibault, L.; Roucou, X. Found in translation: Functions and evolution of a recently discovered alternative proteome. Curr. Opin. Struct. Biol. 2015, 32, 74–80. [Google Scholar] [CrossRef] [PubMed]
- Ivanov, I.P.; Loughran, G.; Atkins, J.F. uORFs with unusual translational start codons autoregulate expression of eukaryotic ornithine decarboxylase homologs. Proc. Natl. Acad. Sci. USA 2008, 105, 10079–10084. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Laumont, C.M.; Daouda, T.; Laverdure, J.-P.; Bonneil, É.; Caron-Lizotte, O.; Hardy, M.-P.; Granados, D.P.; Durette, C.; Lemieux, S.; Thibault, P. Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames. Nat. Commun. 2016, 7, 10238. [Google Scholar] [CrossRef]
- Chong, C.; Müller, M.; Pak, H.; Harnett, D.; Huber, F.; Grun, D.; Leleu, M.; Auger, A.; Arnaud, M.; Stevenson, B.J. Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes. Nat. Commun. 2020, 11, 1293. [Google Scholar] [CrossRef] [Green Version]
- Bartok, O.; Pataskar, A.; Nagel, R.; Laos, M.; Goldfarb, E.; Hayoun, D.; Levy, R.; Körner, P.-R.; Kreuger, I.Z.; Champagne, J. Anti-tumour immunity induces aberrant peptide presentation in melanoma. Nature 2020, 590, 332–337. [Google Scholar] [CrossRef]
- Yan, Y.; Sun, N.; Wang, H.; Kobayashi, M.; Ladd, J.J.; Long, J.P.; Lo, K.C.; Patel, J.; Sullivan, E.; Albert, T. Whole Genome–Derived Tiled Peptide Arrays Detect Prediagnostic Autoantibody Signatures in Non–Small-Cell Lung Cancer. Cancer Res. 2019, 79, 1549–1557. [Google Scholar] [CrossRef] [Green Version]
- Hanash, S.M.; Ostrin, E.J.; Fahrmann, J.F. Blood based biomarkers beyond genomics for lung cancer screening. Transl. Lung Cancer Res. 2018, 7, 327. [Google Scholar] [CrossRef]
- Qiu, J.; Choi, G.; Li, L.; Wang, H.; Pitteri, S.J.; Pereira-Faca, S.R.; Krasnoselsky, A.L.; Randolph, T.W.; Omenn, G.S.; Edelstein, C. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. J. Clin. Oncol. 2008, 26, 5060. [Google Scholar] [CrossRef] [Green Version]
- Pandolfi, P.P. Aberrant mRNA translation in cancer pathogenesis: An old concept revisited comes finally of age. Oncogene 2004, 23, 3134–3137. [Google Scholar] [CrossRef] [Green Version]
- Robichaud, N.; Sonenberg, N.; Ruggero, D.; Schneider, R.J. Translational Control in Cancer. Cold Spring Harb. Perspect. Biol. 2019, 11, a032896. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tripathi, S.C.; Peters, H.L.; Taguchi, A.; Katayama, H.; Wang, H.; Momin, A.; Jolly, M.K.; Celiktas, M.; Rodriguez-Canales, J.; Liu, H. Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome. Proc. Natl. Acad. Sci. USA 2016, 113, E1555–E1564. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schliekelman, M.J.; Taguchi, A.; Zhu, J.; Dai, X.; Rodriguez, J.; Celiktas, M.; Zhang, Q.; Chin, A.; Wong, C.-H.; Wang, H. Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival. Cancer Res. 2015, 75, 1789–1800. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shepherd, F.A.; Lacas, B.; Le Teuff, G.; Hainaut, P.; Jänne, P.A.; Pignon, J.-P.; Le Chevalier, T.; Seymour, L.; Douillard, J.-Y.; Graziano, S. Pooled analysis of the prognostic and predictive effects of TP53 comutation status combined with KRAS or EGFR mutation in early-stage resected non–small-cell lung cancer in four trials of adjuvant chemotherapy. J. Clin. Oncol. 2017, 35, 2018. [Google Scholar] [CrossRef]
- Ameli Mojarad, M.; Ameli Mojarad, M.; Pourmahdian, A. Long Non-coding RNA snaR Promotes Proliferation in EGFR Wild Type Non-Small Cell Lung Cancer Cells. Int. J. Mol. Cell. Med. 2021, 10, 258–264. [Google Scholar]
- Passaro, A.; Stenzinger, A.; Peters, S. Tumor Mutational Burden as a Pan-cancer Biomarker for Immunotherapy: The Limits and Potential for Convergence. Cancer Cell 2020, 38, 624–625. [Google Scholar] [CrossRef]
- Brierley, I.; Jenner, A.J.; Inglis, S.C. Mutational analysis of the “slippery-sequence” component of a coronavirus ribosomal frameshifting signal. J. Mol. Biol. 1992, 227, 463–479. [Google Scholar] [CrossRef]
- Dinman, J.D. Slippery ribosomes prefer shapeshifting mRNAs. Proc. Natl. Acad. Sci. USA 2019, 116, 19225–19227. [Google Scholar] [CrossRef] [Green Version]
- Lambert, J.-M.; Ashi, M.O.; Srour, N.; Delpy, L.; Saulière, J. Mechanisms and Regulation of Nonsense-Mediated mRNA Decay and Nonsense-Associated Altered Splicing in Lymphocytes. Int. J. Mol. Sci. 2020, 21, 1335. [Google Scholar] [CrossRef] [Green Version]
- Rozov, A.; Demeshkina, N.; Westhof, E.; Yusupov, M.; Yusupova, G. Structural insights into the translational infidelity mechanism. Nat. Commun. 2015, 6, 7251. [Google Scholar] [CrossRef] [Green Version]
- Fahrmann, J.F.; Marsh, T.; Irajizad, E.; Patel, N.; Murage, E.; Vykoukal, J.; Dennison, J.B.; Do, K.-A.; Ostrin, E.; Spitz, M.R.; et al. Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. J. Clin. Oncol. 2020, 40, 876–883. [Google Scholar] [CrossRef] [PubMed]
- Ostrin, E.J.; Bantis, L.E.; Wilson, D.O.; Patel, N.; Wang, R.; Kundnani, D.; Adams-Haduch, J.; Dennison, J.B.; Fahrmann, J.F.; Chiu, H.T.; et al. Contribution of a Blood-Based Protein Biomarker Panel to the Classification of Indeterminate Pulmonary Nodules. J. Thorac. Oncol. 2021, 16, 228–236. [Google Scholar] [CrossRef] [PubMed]
- Fahrmann, J.F.; Kim, K.; DeFelice, B.C.; Taylor, S.L.; Gandara, D.R.; Yoneda, K.Y.; Cooke, D.T.; Fiehn, O.; Kelly, K.; Miyamoto, S. Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer. Cancer Epidemiol. Biomark. Prev. 2015, 24, 1716–1723. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rossi, E.; Aieta, M.; Tartarone, A.; Pezzuto, A.; Facchinetti, A.; Santini, D.; Ulivi, P.; Ludovini, V.; Possidente, L.; Fiduccia, P.; et al. A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients. Transl. Lung Cancer Res. 2021, 10, 80–92. [Google Scholar] [CrossRef] [PubMed]
- Wang, H.; Hanash, S. Intact-protein analysis system for discovery of serum-based disease biomarkers. In Serum/Plasma Proteomics; Springer: Berlin/Heidelberg, Germany, 2011; pp. 69–85. [Google Scholar]
- Kobayashi, M.; Katayama, H.; Irajizad, E.; Vykoukal, J.V.; Fahrmann, J.F.; Kundnani, D.L.; Yu, C.-Y.; Cai, Y.; Hsiao, F.C.; Yang, W.-L. Proteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis. Cancers 2020, 12, 485. [Google Scholar] [CrossRef] [Green Version]
- Fahrmann, J.F.; Tanaka, I.; Irajizad, E.; Mao, X.; Dennison, J.B.; Murage, E.; Casabar, J.; Mayo, J.; Peng, Q.; Celiktas, M.; et al. Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma. Cancers 2022, 14, 2543. [Google Scholar] [CrossRef] [PubMed]
- Tanaka, I.; Dayde, D.; Tai, M.C.; Mori, H.; Solis, L.M.; Tripathi, S.C.; Fahrmann, J.F.; Unver, N.; Parhy, G.; Jain, R.; et al. SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas. J. Natl. Cancer Inst. 2022, 114, 290–301. [Google Scholar] [CrossRef]
- Taguchi, A.; Politi, K.; Pitteri, S.J.; Lockwood, W.W.; Faca, V.M.; Kelly-Spratt, K.; Wong, C.H.; Zhang, Q.; Chin, A.; Park, K.S.; et al. Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell 2011, 20, 289–299. [Google Scholar] [CrossRef] [Green Version]
- Goodman, G.E.; Thornquist, M.D.; Balmes, J.; Cullen, M.R.; Meyskens, F.L., Jr.; Omenn, G.S.; Valanis, B.; Williams, J.H., Jr. The Beta-Carotene and Retinol Efficacy Trial: Incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping β-carotene and retinol supplements. J. Natl. Cancer Inst. 2004, 96, 1743–1750. [Google Scholar] [CrossRef] [Green Version]
- Capello, M.; Vykoukal, J.V.; Katayama, H.; Bantis, L.E.; Wang, H.; Kundnani, D.L.; Aguilar-Bonavides, C.; Aguilar, M.; Tripathi, S.C.; Dhillon, D.S. Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity. Nat. Commun. 2019, 10, 254. [Google Scholar] [CrossRef]
- Vaudel, M.; Burkhart, J.M.; Zahedi, R.P.; Oveland, E.; Berven, F.S.; Sickmann, A.; Martens, L.; Barsnes, H. PeptideShaker enables reanalysis of MS-derived proteomics data sets. Nat. Biotechnol. 2015, 33, 22–24. [Google Scholar] [CrossRef] [PubMed]
- Vaudel, M.; Burkhart, J.M.; Sickmann, A.; Martens, L.; Zahedi, R.P. Peptide identification quality control. Proteomics 2011, 11, 2105–2114. [Google Scholar] [CrossRef] [PubMed]
- Reiter, L.; Claassen, M.; Schrimpf, S.P.; Jovanovic, M.; Schmidt, A.; Buhmann, J.M.; Hengartner, M.O.; Aebersold, R. Protein identification false discovery rates for very large proteomics data sets generated by tandem mass spectrometry. Mol. Cell. Proteom. 2009, 8, 2405–2417. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, H.; Joh, Y.S.; Kim, H.; Paek, E.; Lee, S.-W.; Hwang, K.-B. Evaluating the effect of database inflation in proteogenomic search on sensitive and reliable peptide identification. BMC Genom. 2016, 17, 151–162. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nesvizhskii, A.I. A survey of computational methods and error rate estimation procedures for peptide and protein identification in shotgun proteomics. J. Proteom. 2010, 73, 2092–2123. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Irajizad, E.; Fahrmann, J.F.; Long, J.P.; Vykoukal, J.; Kobayashi, M.; Capello, M.; Yu, C.-Y.; Cai, Y.; Hsiao, F.C.; Patel, N.; et al. A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune Response. Int. J. Mol. Sci. 2022, 23, 8933. https://doi.org/10.3390/ijms23168933
Irajizad E, Fahrmann JF, Long JP, Vykoukal J, Kobayashi M, Capello M, Yu C-Y, Cai Y, Hsiao FC, Patel N, et al. A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune Response. International Journal of Molecular Sciences. 2022; 23(16):8933. https://doi.org/10.3390/ijms23168933
Chicago/Turabian StyleIrajizad, Ehsan, Johannes F. Fahrmann, James P. Long, Jody Vykoukal, Makoto Kobayashi, Michela Capello, Chuan-Yih Yu, Yining Cai, Fu Chung Hsiao, Nikul Patel, and et al. 2022. "A Comprehensive Search of Non-Canonical Proteins in Non-Small Cell Lung Cancer and Their Impact on the Immune Response" International Journal of Molecular Sciences 23, no. 16: 8933. https://doi.org/10.3390/ijms23168933